Prognostic factors for lymphedema after primary treatment of breast carcinoma
- PMID: 11745250
- DOI: 10.1002/1097-0142(20011001)92:7<1783::aid-cncr1694>3.0.co;2-g
Prognostic factors for lymphedema after primary treatment of breast carcinoma
Abstract
Background: Lymphedema of the arm is a serious consequence of breast carcinoma treatment. Postmastectomy lymphedema of the upper limb usually is related to certain risk factors such as axillary surgery, radiotherapy, obesity, venous outflow obstruction, delayed wound healing, and infection. The objective of the current study was to identify the risk factors for secondary lymphedema after breast carcinoma treatment.
Methods: A total of 1278 breast carcinoma patients, all of whom were residents of Florence area, Italy at the time of diagnosis and who were operated on by the same surgeon between 1989 and 1997, were included in the current analysis. The circumference of the upper arm was measured and lymphedema was defined as being present when an increase of > 5% of the sum differences between the two arms was found. The observed cumulative probability of lymphedema occurrence was estimated using the Kaplan-Meier method. The Cox proportional hazards models were fitted to assess the relative excess risk of lymphedema and to check for confusing factors. All patients with lymphedema who were living in the Florence area were referred to a specialist for treatment.
Results: Two hundred three cases of lymphedema of the ipsilateral arm were found (15.9%). The right arm was affected in 44.5% of the cases and the left arm in 55.5%. The risk of developing late lymphedema was found to be significantly related to a pathologic T2 classification (hazards ratio [HR] = 1.44; 95% confidence interval [95% CI], 1.06-1.94) and postoperative radiotherapy (HR = 1.35; 95%CI, 1.00-1.83). Patients who had > 30 lymph nodes removed were found to have a borderline increased risk of lymphedema (HR = 1.64; 95% CI, 0.99-2.74). Multivariate analysis identified postoperative radiotherapy (HR = 1.38; 95% CI, 1.02-1.86) and the number of lymph nodes removed (HR = 1.29; 95% CI, 1.04-1.59) to be independent predictors of lymphedema.
Conclusions: The results of the current study demonstrated that the risk of lymphedema was correlated with the use of postoperative radiotherapy and the number of lymph nodes removed.
Copyright 2001 American Cancer Society.
Similar articles
-
The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.Chirurgia (Bucur). 2015 Jan-Feb;110(1):33-7. Chirurgia (Bucur). 2015. PMID: 25800313
-
[Risk factors for lymphedema of the arm after mastectomy for breast cancer].Dakar Med. 1999;44(1):32-5. Dakar Med. 1999. PMID: 10797983 French.
-
The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.Breast Cancer. 2018 May;25(3):309-314. doi: 10.1007/s12282-018-0830-3. Epub 2018 Feb 3. Breast Cancer. 2018. PMID: 29397555
-
[Risk factors for developing upper limb lymphedema after breast cancer treatment].Bull Cancer. 2006 Oct;93(10):1001-6. Bull Cancer. 2006. PMID: 17074659 Review. French.
-
Axillary reverse mapping (ARM): where to go.Breast Cancer. 2019 Jan;26(1):1-10. doi: 10.1007/s12282-018-0886-0. Epub 2018 Jun 30. Breast Cancer. 2019. PMID: 29961238 Review.
Cited by
-
The effect of yoga on women with secondary arm lymphoedema from breast cancer treatment.BMC Complement Altern Med. 2012 May 28;12:66. doi: 10.1186/1472-6882-12-66. BMC Complement Altern Med. 2012. PMID: 22639944 Free PMC article. Clinical Trial.
-
Development of breast cancer-related lymphedema: is it dependent on the patient, the tumor or the treating physicians?Surg Today. 2014 Jan;44(1):100-6. doi: 10.1007/s00595-013-0494-8. Epub 2013 Feb 2. Surg Today. 2014. PMID: 23377553
-
Risk of decline in upper-body function and symptoms among older breast cancer patients.J Gen Intern Med. 2006 Apr;21(4):327-33. doi: 10.1111/j.1525-1497.2006.00384.x. J Gen Intern Med. 2006. PMID: 16686807 Free PMC article.
-
Advanced hemostasis in axillary lymph node dissection for locally advanced breast cancer: new technology devices compared in the prevention of seroma formation.BMC Surg. 2019 Apr 24;18(Suppl 1):125. doi: 10.1186/s12893-018-0454-8. BMC Surg. 2019. PMID: 31074399 Free PMC article.
-
A prospective randomised study of alginate-drenched low stretch bandages as an alternative to conventional lymphologic compression bandaging.Support Care Cancer. 2010 Mar;18(3):343-50. doi: 10.1007/s00520-009-0658-7. Epub 2009 May 31. Support Care Cancer. 2010. PMID: 19484485 Clinical Trial.
MeSH terms
LinkOut - more resources
Medical